Public Health News and Research

RSS

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr virus (EBV), according to a study led by Harvard T.H. Chan School of Public Health researchers.

13 Jan 2022

Higher olive oil intake may reduce the risk of premature death

People who consume higher amounts of olive oil may lower their risk of premature death overall and from specific causes including cardiovascular disease, cancer, and neurodegenerative disease, compared to people who never or almost never consume olive oil, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.

13 Jan 2022

People with COVID-19 can end self-isolation after 5 days following 2 consecutive negative LFD tests

From Monday, 17 January, people with COVID-19 in England can end their self-isolation after five full days, as long as they test negative on day 5 and day 6.

13 Jan 2022

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

Researchers test the durability of antibodies produced by a vaccine-induced full-length SARS-CoV-2 spike protein and receptor-binding domain.

13 Jan 2022

KHN’s ‘What the Health?’: Dealing with drug prices

Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer's drug, to only patients participating in approved clinical trials.

13 Jan 2022

Justices block broad worker vaccine requirement, allow health worker mandate to proceed

The Supreme Court on Thursday blocked a key Biden administration covid-19 initiative — putting a stop, for now, to a rule requiring businesses with more than 100 workers to either mandate that employees be vaccinated against covid or wear masks and undergo weekly testing.

13 Jan 2022

What patients can learn with confidence from one negative rapid test (hint: very little)

Julie Ann Justo, an infectious disease clinical pharmacist for a South Carolina hospital system, hoped Christmas week would finally be the time her family could safely gather for a reunion.

13 Jan 2022

Study reveals stark disparities in air pollution exposure among racial/ethnic, income groups in the U.S.

Certain groups in the U.S.—Blacks, Asians, Hispanics, Latinos, and low-income populations—are being exposed to higher levels of dangerous fine particulate air pollution (PM2.5) than other groups, according to new research from Harvard T.H. Chan School of Public Health.

13 Jan 2022

Researchers detect Delta variant in the blood and placentas of women who had pregnancy complications

A growing body of evidence has linked the Delta variant of SARS-CoV-2, the virus that causes COVID-19, with an increased risk for pregnancy complications, including stillbirths.

13 Jan 2022

Swapping single food item for a more planet-friendly alternative could reduce diet's carbon footprint

If your New Year's resolution is to eat better for the planet, a new Tulane University study finds it may be easier than you think.

13 Jan 2022

Effect of emerging SARS-CoV-2 variants and vaccination status on COVID-19 transmission rates

In a new study, a team of researchers determined the impact of the emerging SARS-CoV-2 variants of concern and vaccination status on the SARS-CoV-2 transmission dynamics.

13 Jan 2022

Researchers develop a website to identify SARS-CoV-2 regional clusters in real-time

Researchers have empowered public health officers to explore the spread of SARS-CoV-2 across the USA and even support public health groups globally to quickly understand and apply insights obtained from the most recent genomic data.

13 Jan 2022

Vaccination offers long-term protection from worst outcomes of COVID-19

Vaccination offers long-lasting protection from the worst outcomes of COVID-19, according to a new study by the University of North Carolina at Chapel Hill.

13 Jan 2022

Long-excluded uterine cancer patients are step closer to 9/11 benefits

Tammy Kaminski can still recall the taste of benzene, a carcinogenic byproduct of burning jet fuel. For nine months after the 9/11 attacks, she volunteered for eight hours every Saturday at St. Paul's Chapel, just around the corner from ground zero in New York City.

13 Jan 2022

Nanovaccines and their immunomodulatory effect against human viruses

A review ]presented the primary progress of nanovaccines against the main viral illnesses.

13 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

A clinical tool for monoclonal antibody allocation to treat COVID-19

In this research paper, a group of Mayo Clinic researchers discusses how data from MATRx's clinical prioritizing algorithms can be used to address anti-spike monoclonal antibody allocation during times of scarcity.

13 Jan 2022

The zoonotic potential of epidemic porcine deltacoronavirus

The present state of knowledge about the genesis, evolution, cross-species transmission, and zoonotic potential of PDCoV is the subject of a review published in the journal Pathogens, which was conducted in a combined effort by researchers from Heilongjiang Bayi Agricultural University and Ohio State University.

13 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Survey helps understand the experiences of physicians who provide medical aid in dying

In 2016, Colorado voters approved a new state law that provided medical aid in dying for terminally ill patients. This law authorizes a physician, who is identified as the attending physician, to prescribe a lethal dose of medications that results in death.

12 Jan 2022

Public Health News and Research

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Higher olive oil intake may reduce the risk of premature death

People with COVID-19 can end self-isolation after 5 days following 2 consecutive negative LFD tests

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

KHN’s ‘What the Health?’: Dealing with drug prices

Justices block broad worker vaccine requirement, allow health worker mandate to proceed

What patients can learn with confidence from one negative rapid test (hint: very little)

Study reveals stark disparities in air pollution exposure among racial/ethnic, income groups in the U.S.

Researchers detect Delta variant in the blood and placentas of women who had pregnancy complications

Swapping single food item for a more planet-friendly alternative could reduce diet's carbon footprint

Effect of emerging SARS-CoV-2 variants and vaccination status on COVID-19 transmission rates

Researchers develop a website to identify SARS-CoV-2 regional clusters in real-time

Vaccination offers long-term protection from worst outcomes of COVID-19

Long-excluded uterine cancer patients are step closer to 9/11 benefits

Nanovaccines and their immunomodulatory effect against human viruses

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A clinical tool for monoclonal antibody allocation to treat COVID-19

The zoonotic potential of epidemic porcine deltacoronavirus

How did the COVID pandemic affect the spread of other zoonotic diseases?

Survey helps understand the experiences of physicians who provide medical aid in dying

News Medical 2025: Healthcare Shifts That Mattered Most eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News